Dr. Reddy's Labs Files 6-K Report

Ticker: RDY · Form: 6-K · Filed: Jul 15, 2025 · CIK: 1135951

Sentiment: neutral

Topics: sec-filing, regulatory, foreign-private-issuer

TL;DR

DRL files 6-K, confirming 20-F annual report filing. Standard compliance update.

AI Summary

Dr. Reddy's Laboratories Limited filed a Form 6-K on July 15, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer and will file its annual reports under Form 20-F.

Why It Matters

This filing indicates Dr. Reddy's Laboratories is complying with SEC reporting requirements as a foreign private issuer, providing transparency to investors.

Risk Assessment

Risk Level: low — This is a routine regulatory filing and does not contain new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public in its home country.

Which annual report form does Dr. Reddy's Laboratories Limited file?

Dr. Reddy's Laboratories Limited files its annual reports under cover of Form 20-F.

Where is Dr. Reddy's Laboratories Limited headquartered?

Dr. Reddy's Laboratories Limited is headquartered at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

What is the Standard Industrial Classification code for Dr. Reddy's Laboratories Limited?

The Standard Industrial Classification code for Dr. Reddy's Laboratories Limited is 2834, which corresponds to Pharmaceutical Preparations.

What is the SEC file number for Dr. Reddy's Laboratories Limited?

The SEC file number for Dr. Reddy's Laboratories Limited is 001-15182.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 15, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing